نتائج البحث

1

دورية أكاديمية

THE PATTERN OF URINARY CHONDROITIN SULFATE AND CHONDROITIN EXCRETION WITH AGE

المؤلفون: CHIKAI YASUOKA, EIHAKU IWATANI, IRA GORE, ISOKO TAKAZONO, YUKIO TANAKA

المصدر: The Kurume Medical Journal. 1975, 22(3):153

View record in JSTAGE

النص الكامل

2

دورية أكاديمية

THE PATHOLOGY AND PATHOGENESIS OF ATHEROSCLEROSIS

المؤلفون: IRA GORE

المصدر: The Kurume Medical Journal. 1979, 26(1):75

View record in JSTAGE

النص الكامل

3

دورية أكاديمية

Acid Mucopolysaccharides, Cholesterol, Calcium, and Magnesium Content of Japanese Aortas

المؤلفون: Ira GORE, Kazuhiro TAMARI, Motoomi NAKAMURA, Noriko YABUTA, Shinichiro TORII, Tamaki IMAI, Yasushi ISHIHARA

المصدر: Japanese Heart Journal. 1965, 6(1):20

View record in JSTAGE

النص الكامل

4

دورية أكاديمية

Fibrinolytic Activity of the Endothelium

المؤلفون: IRA GORE, TAKAO FUJINAMI

المصدر: JAPANESE CIRCULATION JOURNAL. 1967, 31(2):267

View record in JSTAGE

النص الكامل

5

دورية أكاديمية

ARTERIAL ACID MUCOPOLYSACCHARIDES FOLLOWING VITAMIN D INDUCED INJURY

المؤلفون: IRA GORE, YUKIO TANAKA

المصدر: The Kurume Medical Journal. 1969, 16(1):43

View record in JSTAGE

النص الكامل

6

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial

المصدر: European Journal of Cancer. 184:48-59

مصطلحات موضوعية: Cancer Research, Oncology, Breast Neoplasms, Chemotherapy, Adjuvant, Kaplan–Meier estimate, Neratinib, Receptor ErbB-2, Survival analysis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f52b3f56c3541c7f92ad50e9e346cadTest
https://doi.org/10.1016/j.ejca.2023.02.002Test

7

Supplementary Figure 3 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

المؤلفون: Jennifer A. Low, Gordon L. Bray, Richard A. Graham, Robert L. Yauch, Howard M. Mackey, Mark M. Zalupski, Mary F. Mulcahy, Robert C. Hermann, Ira Gore, Irfan Firdaus, Lowell L. Hart, Johanna C. Bendell, Jordan Berlin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b2a6e969d7ebf392680c04fd803180Test
https://doi.org/10.1158/1078-0432.22445865.v1Test

8

Supplementary Figure 5 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

المؤلفون: Jennifer A. Low, Gordon L. Bray, Richard A. Graham, Robert L. Yauch, Howard M. Mackey, Mark M. Zalupski, Mary F. Mulcahy, Robert C. Hermann, Ira Gore, Irfan Firdaus, Lowell L. Hart, Johanna C. Bendell, Jordan Berlin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44bd20ab21ff0722fc5839feb51cd58cTest
https://doi.org/10.1158/1078-0432.22445859Test

9

Supplementary Table 1 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

المؤلفون: Jennifer A. Low, Gordon L. Bray, Richard A. Graham, Robert L. Yauch, Howard M. Mackey, Mark M. Zalupski, Mary F. Mulcahy, Robert C. Hermann, Ira Gore, Irfan Firdaus, Lowell L. Hart, Johanna C. Bendell, Jordan Berlin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b4e0a40936477e3510849a4be74ccbTest
https://doi.org/10.1158/1078-0432.22445853Test

10

Data from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

المؤلفون: Jennifer A. Low, Gordon L. Bray, Richard A. Graham, Robert L. Yauch, Howard M. Mackey, Mark M. Zalupski, Mary F. Mulcahy, Robert C. Hermann, Ira Gore, Irfan Firdaus, Lowell L. Hart, Johanna C. Bendell, Jordan Berlin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443cdb742525f6999d7cda631cb7855cTest
https://doi.org/10.1158/1078-0432.c.6520578.v1Test

تنقيح النتائج